Cytochrome P-450 CYP2C9 Inducers (moderate)
- Name
- Cytochrome P-450 CYP2C9 Inducers (moderate)
- Accession Number
- DBCAT003109
- Description
Not Available
- Drugs
Drug Drug Description Bosentan A dual endothelin receptor antagonist used to treat pulmonary arterial hypertension. Enzalutamide A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. Alpelisib Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... Rifampicin An antibiotic used to treat several types of mycobacterial infections including Mycobacterium avium complex, leprosy, and in combination with other antibacterials to treat latent or active tuberculosis. - Drugs & Drug Targets